Establishing statewide standards governing the use of HIV post-exposure prophylaxis, permitting a pharmacist to initiate such medication to certain patients, providing civil liability protections to pharmacists who initiate prophylactic therapy to patients for post-exposure to human immunodeficiency virus.
About This Bill
Latest Action · Apr 10, 2026
Died in Committee
Session
2025-2026
Introduced
Jan 27, 2025
Primary Sponsor
Brandon Woodard· primary
Subjects
Boards, Commissions and Task ForcesPharmacists and Pharmacy